These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 21335659)

  • 1. Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics.
    Kuljiš RO; Salković-Petrišić M
    J Alzheimers Dis; 2011; 25(1):29-41. PubMed ID: 21335659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin.
    Moreira PI
    J Alzheimers Dis; 2012; 30 Suppl 2():S199-215. PubMed ID: 22269163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impairment of insulin signaling in Alzheimer's disease.
    Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
    IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in the brain: an old-age or new-age problem?
    Williamson R; McNeilly A; Sutherland C
    Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?
    Frisardi V; Solfrizzi V; Capurso C; Imbimbo BP; Vendemiale G; Seripa D; Pilotto A; Panza F
    J Alzheimers Dis; 2010; 21(1):57-63. PubMed ID: 20421697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral insulin and brain structure in early Alzheimer disease.
    Burns JM; Donnelly JE; Anderson HS; Mayo MS; Spencer-Gardner L; Thomas G; Cronk BB; Haddad Z; Klima D; Hansen D; Brooks WM
    Neurology; 2007 Sep; 69(11):1094-104. PubMed ID: 17846409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
    Kroner Z
    Altern Med Rev; 2009 Dec; 14(4):373-9. PubMed ID: 20030463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet and Alzheimer's disease risk factors or prevention: the current evidence.
    Solfrizzi V; Panza F; Frisardi V; Seripa D; Logroscino G; Imbimbo BP; Pilotto A
    Expert Rev Neurother; 2011 May; 11(5):677-708. PubMed ID: 21539488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.
    Takeda S; Sato N; Rakugi H; Morishita R
    Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic links between diabetes and Alzheimer's disease.
    Maher PA; Schubert DR
    Expert Rev Neurother; 2009 May; 9(5):617-30. PubMed ID: 19402773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diabetic brain and cognition.
    Riederer P; Korczyn AD; Ali SS; Bajenaru O; Choi MS; Chopp M; Dermanovic-Dobrota V; Grünblatt E; Jellinger KA; Kamal MA; Kamal W; Leszek J; Sheldrick-Michel TM; Mushtaq G; Meglic B; Natovich R; Pirtosek Z; Rakusa M; Salkovic-Petrisic M; Schmidt R; Schmitt A; Sridhar GR; Vécsei L; Wojszel ZB; Yaman H; Zhang ZG; Cukierman-Yaffe T
    J Neural Transm (Vienna); 2017 Nov; 124(11):1431-1454. PubMed ID: 28766040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
    Henry-Feugeas MC
    Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain insulin resistance may exacerbate Alzheimer's progression. Researchers call it "Type III" diabetes.
    Duke Med Health News; 2012 Sep; 18(9):4-5. PubMed ID: 23029691
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?
    Biessels GJ; Kappelle LJ;
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1041-4. PubMed ID: 16246041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease.
    Ferreira ST; Clarke JR; Bomfim TR; De Felice FG
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S76-83. PubMed ID: 24529528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factors, AGEing, and the diabetes link in Alzheimer's disease.
    Loy CT; Twigg SM
    J Alzheimers Dis; 2009; 16(4):823-31. PubMed ID: 19387115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin and Alzheimer's disease: untangling the web.
    Craft S; Cholerton B; Baker LD
    J Alzheimers Dis; 2013; 33 Suppl 1():S263-75. PubMed ID: 22936011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus.
    Valente T; Gella A; Fernàndez-Busquets X; Unzeta M; Durany N
    Neurobiol Dis; 2010 Jan; 37(1):67-76. PubMed ID: 19778613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.